Epigenetics & chromatin
Correction: Acetylation modification of AIM2 by KAT2B suppresses the AKT/Wnt/β-catenin signaling pathway activation and inhibits breast cancer progression.
Yaqiong Li, Lingcheng Wang, Wei Wanga, Wei Wangb, Wei Huang, Shengchun Liu
Published: 202510.1186/s13072-025-00645-y
No abstract available for this study.